The act creates the drug repository task force (task force) in the department of public health and environment (department) to examine drug repository programs for unused prescription drugs and over-the-counter medications in the country to determine the best model to implement for Colorado.
The task force consists of at least 13 and no more than 15 members, including up to 8 members appointed by the executive director of the department, 6 members appointed by the executive director of the department of regulatory agencies, and one member appointed by the department of health care policy and financing representing that department. The task force members include, in part, representatives of impacted state departments, hospitals, pharmacists and pharmacy associations, physicians, and members representing patients. The task force members must be appointed by August 1, 2022.
The executive director of the department or the executive director's designee shall convene the task force no later than September 15, 2022. In part, the task force shall consider drug depository programs in other states and which model is the safest and most efficient and effective model for Colorado; medications to be included in the program; the requirements for donating and receiving medications; legal issues; and fees and rule-making for the program. The department shall provide staff support to the task force. The task force shall report its findings and recommendations to the governor and the health committees of the general assembly by December 15, 2022. The task force is repealed on July 1, 2023.
(Note: This summary applies to this bill as enacted.)